Hennion & Walsh Asset Management »

Vir Biotechnology shares owned by Hennion & Walsh Asset Management

Quarter-by-quarter ownership of Vir Biotechnology (VIR) shares owned by Hennion & Walsh Asset Management from 13F filings

Historical chart of Hennion & Walsh Asset Management investment in Vir Biotechnology

Tip: Access up to 7 years of quarterly data

All positions including Vir Biotechnology held by Hennion & Walsh Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vir Biotechnology by Hennion & Walsh Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $263k 35k 7.49
2024-06-30 $346k 39k 8.90
2024-03-31 $397k 39k 10.13
2023-12-31 $344k 34k 10.06
2023-09-30 $325k 35k 9.37
2023-06-30 $790k 32k 24.53
2023-03-31 $735k 32k 23.28
2022-12-31 $664k 26k 25.33

More positions owned by Hennion & Walsh Asset Management

Goldman Sachs Etf Tr Activebeta Us Lg (GSLC)
Proshares Tr S&p 500 High Inc (ISPY)
Ishares Tr Investment Grade (IGEB)
Wisdomtree Tr Intl Qulty Div (IQDG)
Ishares Tr Core S&p500 Etf (IVV)
Global X Fds Us Pfd Etf (PFFD)
Goldman Sachs Etf Tr Activebeta Int (GSIE)
Wisdomtree Tr Us S Cap Qty Div (DGRS)
J P Morgan Exchange Traded F Us Qualty Fctr (JQUA)
Vanguard Index Fds Value Etf (VTV)
NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Nuveen Insured Tax-Free Adv Munici (NEA)
Nuveen Municipal Credit Com Sh Ben Int (NZF)
Apple (AAPL)

View all positions for Hennion & Walsh Asset Management

Top funds holding Vir Biotechnology

Sb Investment Advisers
BlackRock
Vanguard Group
State Street Corporation
OrbiMed Advisors
Geode Capital Management
Dimensional Fund Advisors
Jpmorgan Chase & Co
Millennium Management
Ikarian Capital
Bill & Melinda Gates Foundation
Charles Schwab Investment Management
Renaissance Technologies
Morgan Stanley
Baker Bros. Advisors

View all funds holding Vir Biotechnology